4.6 Article

High-resolution metabolomics determines the mode of onset of type 2 diabetes in a 3-year prospective cohort study

期刊

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
卷 41, 期 2, 页码 1069-1077

出版社

SPANDIDOS PUBL LTD
DOI: 10.3892/ijmm.2017.3275

关键词

liquid chromatography-mass spectrometry; type 2 diabetes; metabolomics; cholesterol

资金

  1. Indonesia Endowment Fund for Education [A-3468/LPDP.3/2015]
  2. Korea Health Industry Development Institute [HI14C2686]
  3. National Foundation of Korea [NRF-2017R1A2B4003890, NRF-2017M3A9F1031229]

向作者/读者索取更多资源

Type 2 diabetes mellitus (DM) is a progressive disease and the rate of progression from non-diabetes to DM varies considerably between individuals, ranging from a few months to many years. It is important to understand the mechanisms underlying the progression of diabetes. In the present study, a high-resolution metabolomics (HRM) analysis was performed to detect potential biomarkers and pathways regulating the mode of onset by comparing subjects who developed and did not develop type 2 DM at the second year in a 3-year prospective cohort study. Metabolic profiles correlated with progression to DM were examined. The subjects (n=98) were classified into four groups: Control (did not develop DM for 3 years), DM (diagnosed with DM at the start of the study), DM onset at the third year and DM onset at the second year. The focus was on the comparison of serum samples of the DM groups with onset at the second and third year from the first year, where these two groups had not developed DM, yet. Analyses involved sample examination using liquid chromatography-mass spectrometry-based HRM and multivariate statistical analysis of the data. Metabolic differences were identified across all analyses with the affected pathways involved in metabolism associated with steroid biosynthesis and bile acid biosynthesis. In the first year, higher levels of cholesterol {mass-to charge ratio (m/z) 369.35, (M+H-H2O)(+)}, 25-hydroxycholesterol [m/z 403.36, (M+H)(+)], 3,7-dihydroxy-5 beta-cholestane [m/z 443.33, (M+K)(+)], 4 alpha-methylzymosterol-4-carboxylate [m/z 425.34, (M+H-H2O)(+)], and lower levels of 24,25-dihydrolanosterol [m/z 429.40, (M+H)(+)] were evident in the group with DM onset at the second year compared with those in the group with DM onset at the third year. These results, with a focus on the cholesterol biosynthesis pathway, point to important aspects in the development of DM and may aid in the development of more effective means of treatment and prevention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据